Navigation Links
Clam embryo study shows pollutant mixture adversely affects nerve cell development

A scientist at the Marine Biological Laboratory (MBL) has published the results of an EPA-funded clam embryo study that supports her hypothesis that, when combined, the pollutants bromoform, chloroform, and tetrachloroethylene--a chemical cocktail known as BCE--can act synergistically to alter a key regulator in nerve cell development. While scientists have previously studied the effects of these pollutants individually, this is the first time anyone has demonstrated that BCE's components can work together to adversely affect neuron growth in a model organism. The study, which is reported in the January 2005 issue of Environmental Toxicology and Pharmacology, is the first step toward understanding how exposure to BCE might affect human nerve cell development--knowledge that may one day provide clues about such neurological mysteries as autism spectrum disorder or attention deficit hyperactivity disorder.

To test her hypothesis, MBL scientist Carol Reinisch and her colleagues treated developing surf clam embryos (Spisula solidissima) with different combinations of BCE and studied their effects on nerve cell growth. "On a cellular level, clam neurons are extremely useful in studying basic mechanisms of cell development," says Reinisch, an expert in PCB-induced neurotoxicity. "Of the different combinations and strengths of BCE components tested, we found that all three together induce the greatest adverse response. Treating the embryos with the triple mixture resulted in increased production of a subunit of an enzyme called protein kinase A (PKA), which previous research suggests plays a role in neural development," says Reinisch. "Fluctuations in PKA may influence not only neuronal maturation but also how neuronal networks are constructed during development," she says. Alterations of this enzyme may affect neural development and neural connections by activating or inactivating other proteins. Demonstrating that clam embryos are affected by BCE paves the way for
'"/>

Source:Eurekalert


Page: 1 2 3

Related biology news :

1. Priming embryonic stem cells to fulfill their promise
2. Current human embryonic stem cell lines contaminated UCSD/Salk team finds
3. Researchers devise way to mass-produce embryonic stem cells
4. Researchers find new genes necessary to make embryo
5. Protein helps regulate the genes of embryonic stem cells
6. Scientists discover that three overlapping signals in embryo help get the backbone right
7. Breakthrough isolating embryo-quality stem cells from blood
8. Vitamin As paradoxical role in influencing symmetry during embryonic development revealed
9. Scientists succeed in cloning human embryos from eggs matured in the lab
10. Human embryonic stem cells have the potential to develop into eggs and sperm in the laboratory
11. Canadas first embryonic stem cell lines
Post Your Comments:
(Date:2/10/2015)... 2015  Alere Inc. (NYSE: ALR), a global ... for the quarter ended December 31, 2014. ... of Alere said, "We made substantial progress in ... global leader in rapid diagnostics and delivering against ... divestiture in early January enabled us to substantially ...
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
(Date:2/5/2015)... , Jan. 27, 2015   ... of globally deployed, innovative test solutions for ... the delivery of its TS-323 GENASYS ... Systems Company (LMSSC). GENASYS is a high-performance ... of mission-critical applications that require performance functional ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... School of Medicine a three-year grant of more than $3 ... contribute to the development of autism. Stephen T. Warren, ... principal investigator of the program project that also includes Michael ... in human genetics. Autism occurs four to nine ...
... tiny grains resembling powder, which is extremely difficult to ... Synchrotron Radiation Facility (ESRF) and the Centre National de ... determine the structure of microcrystal grains of one cubic ... the size of the analysable samples, opening up new ...
... help reduce the risk of pancreatic cancer, says a ... naturally in apples and onions, has been identified as ... reducing the risk of pancreatic cancer. Although the ... who consumed foods rich in flavonols had a significantly ...
Cached Biology News:Simons Foundation awards Emory scientists $3M for autism gene research 2Unveiling the structure of microcrystals 2Naturally-occurring apple compounds reduce risk of pancreatic cancer 2
(Date:3/4/2015)... Mar. 04, 2015 Research and Markets ... of the "Global Biologics and Biosimilars Industry ... , The Global Biologics and Biosimilars ... study on the current state of the biologics ... a basic overview of the industry including definitions, ...
(Date:3/4/2015)... Proove Biosciences , a commercial ... to announce the launch of their CME-accredited course ... of Pain”. , The continuing medical education program ... year. The focus of the program is to ... treatments, integrate appropriate pain management techniques, and incorporate ...
(Date:3/4/2015)... SEOUL, South Korea , March 4, 2015 /PRNewswire/ ... based biopesticide company, in August of last year. As ... with Kyung Bon Koo continuing his role ... Selakovic , President of Vegalab S.A., will work alongside ... Photo - http://photos.prnewswire.com/prnh/20150303/179218 ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... Hopitaux de Paris en ... «   SARAH   », qui compare   ... l,yttrium-90 avec le   sorafénib dans le carcinome ... atteints d,un cancer du foie avancé   ; ...
Breaking Biology Technology:Global Biologics and Biosimilars Industry Report 2015-2020 2Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6
... PETLinQ(R) LLC is extremely proud to,announce the release ... RISLinQ(R) 4.0Mac provides full end to end workflow,capability for ... , Harsha Hatti, President and CEO of ... class, well respected and highly credible operating system that,many ...
... HUBEI PROVINCE, China, Nov. 18 ,Benda Pharmaceutical, Inc. (OTC ... a commercialized gene,therapy medicine for the treatment of cancer, ... for the three and,nine month periods ended September 30, ... with the SEC today. , ...
... its extensive experience in multi-GPU high-performance computing ... to provide scientists, engineers and researchers with ... Personal Supercomputer (PSC), which will be shown ... week,s SC08 Conference, the top international conference ...
Cached Biology Technology:PETLinQ Launches RISLinQ 4.0Mac on Mac OS X Platform 2Benda Pharmaceutical Reports Third Quarter 2008 Financial Results 2Benda Pharmaceutical Reports Third Quarter 2008 Financial Results 3Benda Pharmaceutical Reports Third Quarter 2008 Financial Results 4Benda Pharmaceutical Reports Third Quarter 2008 Financial Results 5Benda Pharmaceutical Reports Third Quarter 2008 Financial Results 6Benda Pharmaceutical Reports Third Quarter 2008 Financial Results 7Benda Pharmaceutical Reports Third Quarter 2008 Financial Results 8Benda Pharmaceutical Reports Third Quarter 2008 Financial Results 9BOXX Personal Supercomputer for Research Scientists Featured at SC08 2
Request Info...
Form: Concentrated Applications: ELISA...
Agarase cleaves agarose to neoagaro-oligosaccharides, and is used for,quantitative, gentle recovery of DNA from low melting point agarose....
Form: Ready to use Applications: ELISA...
Biology Products: